Immunohistochemical and electronmicroscopic features of mesenchymal-to-epithelial transition in human developing, postnatal and nephrotic podocytes.
Differentiation of human podocytes starts with mesenchymal-to-epithelial transition (MET) of the metanephric mesenchyme into the S-shaped nephrons. During further development, differentiating podocytes regain mesenchyme-like cell characteristics by epithelial-to-mesenchymal transition (EMT), leading to formation of the terminally differentiated, non-dividing cell. Both MET and EMT processes involve changes in content and organization of cytoskeletal and actin filaments, accompanied by the increased glomerular vascularization. Here, we analyze and compare normal human developing, postnatal and nephrotic podocytes and glomeruli, using immunohistochemical and double immunofluorescent methods for detection of markers of cytoskeletal filaments (nestin, cytokeratin 10-CK10, vimentin and α-SMA), vasculogenesis (CD31 and VEGF) and podocyte function (receptor for advanced glycation end products, RAGE). In addition, electron microscopy is used to detect ultrastructural changes of the podocytes. Early metanephric cup mesenchyme expresses all investigated markers except α-SMA, which characterizes only surface mesenchymal cells. In differentiating podocytes and cells of Bowman's capsule (parietal podocytes) nestin decreases, vimentin increases, while CK10 gradually disappears. Increase in α-SMA is associated with blood vessels development, appearance of podocyte pedicles and slit diaphragm and loss of intercellular connections (zonulae adherentes). Increase in CD31 characterizes vascular glomerular tufts development, while decrease in RAGE expression accompanies normal podocyte differentiation. In congenital nephrotic syndrome of the Finnish type, dedifferentiated podocytes display changes in cytoskeletal filaments and depletion of podocyte pedicles, while glomerular vascular supply is diminished. Our data also suggest high potential of metanephric mesenchyme and parietal podocytes in possible regeneration of the damaged podocytes.
Department of Anatomy, Histology and Embryology, School of Medicine, University of Split, Soltanska 2, 21000, Split, Croatia.
Natalija
N
Filipovic
Department of Anatomy, Histology and Embryology, School of Medicine, University of Split, Soltanska 2, 21000, Split, Croatia.
Katarina
K
Vukojevic
Department of Biology, University of Split, Split, Croatia.
Ivana
I
Bocina
Department of Pediatrics, University Hospital in Split, Split, Croatia.
Marijan
M
Saraga
Department of Pathology, University Hospital in Split, Split, Croatia.
Merica Glavina
MG
Durdov
Department of Medical Neuroscience (Anatomy Division), Faculty of Medicine, Dalhousie University, Halifax, Canada.
Boris
B
Kablar
Department of Anatomy, Histology and Embryology, School of Medicine, University of Split, Soltanska 2, 21000, Split, Croatia. msb@mefst.hr.
Mirna
M
Saraga-Babic
D058750:Epithelial-Mesenchymal Transition; D006801:Humans; D007150:Immunohistochemistry; D008854:Microscopy, Electron; D009404:Nephrotic Syndrome / Q000378:metabolism* / Q000473:pathology*; D050199:Podocytes / Q000166:cytology* / Q000473:pathology / Q000648:ultrastructure*
Congenital nephrotic syndrome of the Finnish type; Cytoskeletal filaments; Human kidney development; Mesenchymal-to-epithelial transition; Podocytes
Lab Invest. 1991 Jun;64(6):777-84
2046329
Kidney Int. 2007 Oct;72(8):965-76
17667983
Am J Physiol. 1997 Jul;273(1 Pt 2):F150-7
9249603
Hum Mol Genet. 2009 Oct 15;18(R2):R185-94
19808795
Nat Rev Mol Cell Biol. 2014 Mar;15(3):163-77
24556839
Kidney Int. 1992 Mar;41(3):657-64
1573843
Cancer Res. 2007 Oct 1;67(19):9199-206
17909025
J Histochem Cytochem. 2003 Feb;51(2):141-50
12533522
J Am Soc Nephrol. 2006 May;17(5):1283-91
16571784
Pediatr Nephrol. 2006 May;21(5):627-36
16568307
Dev Biol. 2008 Jan 1;313(1):234-45
18061157
Nat Genet. 2000 Mar;24(3):251-6
10700177
J Am Soc Nephrol. 2007 Dec;18(12 ):3128-38
17978305
J Am Soc Nephrol. 2009 May;20(5):1041-52
19389856
BMC Nephrol. 2014 Jan 08;15:3
24397250
Nature. 2015 Oct 22;526(7574):564-8
26444236
Nephrol Dial Transplant. 2012 Aug;27(8):3129-36
22510380
J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:129-33
20836739
Development. 2008 Feb;135(4):609-20
18184729
Diabetes. 2011 Jun;60(6):1779-88
21521871
J Am Soc Nephrol. 2009 Feb;20(2):322-32
19092120
Tohoku J Exp Med. 2007 May;212(1):81-90
17464107
Physiol Rev. 2003 Jan;83(1):253-307
12506131
Front Endocrinol (Lausanne). 2014 Oct 01;5:148
25324828
Am J Pathol. 1998 Nov;153(5):1511-20
9811343
EMBO J. 2006 Nov 1;25(21):5214-28
17036046
Biochem Biophys Res Commun. 2014 Feb 21;444(4):473-9
24472557
Methods Enzymol. 2016;568:113-38
26795469
Anat Rec (Hoboken). 2010 Nov;293(11):1971-83
20818613
Lab Invest. 2008 Apr;88(4):387-97
18268475
Dev Biol. 2008 Dec 1;324(1):88-98
18835385
J Am Soc Nephrol. 2009 Jun;20(6):1179-87
19470685
Eur J Oral Sci. 2012 Aug;120(4):283-91
22813218
J Am Soc Nephrol. 2006 Sep;17 (9):2443-56
16885410
Am J Pathol. 2010 Jan;176(1):85-97
20008127
Am J Pathol. 2003 Apr;162(4):1123-37
12651605
J Mol Histol. 2008 Jun;39(3):339-49
18415689
PLoS One. 2012;7(9):e46453
23029522
Kidney Int. 2000 May;57(5):1836-46
10792602
Kidney Int Suppl. 1993 Jul;42:S35-9
8361126
J Am Soc Nephrol. 2006 Oct;17(10):2770-80
16943305
Am J Surg Pathol. 2005 Jun;29(6):747-54
15897741
Am J Pathol. 1986 Dec;125(3):465-75
2432791
Pediatr Nephrol. 2012 Jan;27(1):55-63
21688189
Nephron Exp Nephrol. 2014;126(2):97
24854649
Cell. 1990 Feb 23;60(4):585-95
1689217
J Mol Histol. 2008 Apr;39(2):227-35
18080773
Cancer Res. 2002 Jul 15;62(14):4123-31
12124351
Cold Spring Harb Perspect Biol. 2012 May 01;4(5):null
22550230
Nephrol Dial Transplant. 1999;14 Suppl 1:48-51
10048450
Cell Stem Cell. 2008 Aug 7;3(2):169-81
18682239
Kidney Int Suppl (2011). 2011 Sep;1(3):83-86
25018906
J Cell Sci. 2011 May 1;124(Pt 9):1363-72
21502133
J Mol Histol. 2013 Feb;44(1):55-63
23070517
J Histochem Cytochem. 2007 Apr;55(4):411-21
17210924
J Mol Med (Berl). 1998 Mar;76(3-4):172-83
9535550
Pediatr Nephrol. 2017 Feb;32(2):195-200
26868670